Home/Filings/4/0001754429-24-000013
4//SEC Filing

PLATT DAVID 4

Accession 0001754429-24-000013

CIK 0001445815other

Filed

Oct 27, 8:00 PM ET

Accepted

Oct 28, 6:06 PM ET

Size

7.0 KB

Accession

0001754429-24-000013

Insider Transaction Report

Form 4
Period: 2024-10-25
PLATT DAVID
DirectorCEO10% Owner
Transactions
  • Other

    Preferred

    2024-10-25$0.28/sh14,085,410$4,014,3420 total(indirect: through NDPD Pharma)
  • Other

    Preferred

    2024-10-25$0.55/sh+11,190,077$6,098,59219,795,532 total
Footnotes (3)
  • [F1]The shares were returned to treasury and cancelled.
  • [F2]The total holdings in BIXT by NDPD Pharma, Inc., an affiliate whose beneficial ownership includes Mike Sheikh, Ola Soderquist, and David Platt, were consolidated under indirect ownership in Davis Platt's filing.
  • [F3]The shares were issued as payment for the sale of NDPD Pharma to Bioxytran

Issuer

BIOXYTRAN, INC

CIK 0001445815

Entity typeother

Related Parties

1
  • filerCIK 0001166440

Filing Metadata

Form type
4
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 6:06 PM ET
Size
7.0 KB